The estimated Net Worth of James Hollingshead is at least $28.5 Milione dollars as of 28 August 2023. Dr Hollingshead owns over 5,550 units of Resmed stock worth over $8,644,047 and over the last 12 years he sold RMD stock worth over $18,414,957. In addition, he makes $1,426,626 as Pres of Sleep & Respiratory Care Bus. at Resmed.
Sign up
Dr D RMD stock SEC Form 4 insiders trading
Dr has made over 71 trades of the Resmed stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 5,550 units of RMD stock worth $1,006,826 on 28 August 2023.
The largest trade he's ever made was exercising 22,903 units of Resmed stock on 11 November 2014 worth over $1,171,488. On average, Dr trades about 2,216 units every 32 days since 2013. As of 28 August 2023 he still owns at least 34,177 units of Resmed stock.
You can see the complete history of Dr Hollingshead stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. James R. Hollingshead Ph.D. biography
Dr. James R. Hollingshead Ph.D. is the Pres of Sleep & Respiratory Care Bus. at Resmed.
What is the salary of Dr D?
As the Pres of Sleep & Respiratory Care Bus. of Resmed, the total compensation of Dr D at Resmed is $1,426,626. There are 9 executives at Resmed getting paid more, with Michael Farrell having the highest compensation of $10,429,800.
How old is Dr D?
Dr D is 58, he's been the Pres of Sleep & Respiratory Care Bus. of Resmed since . There are 11 older and 11 younger executives at Resmed. The oldest executive at Resmed Inc. is Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD, 79, who is the Founder & Non-Exec. Chairman.
What's Dr D's mailing address?
James's mailing address filed with the SEC is C/O INSULET CORPORATION, 100 NAGOG PARK, ACTON, MA, 01720.
Insiders trading at Resmed
Over the last 23 years, insiders at Resmed have traded over $250,830,262 worth of Resmed stock and bought 10,000 units worth $424,500 . The most active insiders traders include Peter C Farrell, Gary W Pace e David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of $3,005,701. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth $246,420.
What does Resmed do?
at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
What does Resmed's logo look like?
Complete history of Dr Hollingshead stock trades at Insulet e Resmed
Resmed executives and stock owners
Resmed executives and other stock owners filed with the SEC include:
-
Michael Farrell,
Chief Executive Officer, Director -
Robert Douglas,
President, Chief Operating Officer -
Jim Hollingshead,
President – sleep and respiratory care business -
Rajwant Sodhi,
President – Software as a Service Business (SaaS) -
Brett Sandercock,
Chief Financial Officer -
Michael J. Farrell BE, SM, MBA,
CEO & Director -
David Pendarvis,
Chief Administrative Officer, Global General Counsel, Secretary -
Michael J. Farrell BE, MBA, SM,
CEO & Director -
Robert A. Douglas,
Pres & COO -
Dr. James R. Hollingshead Ph.D.,
Pres of Sleep & Respiratory Care Bus. -
Brett A. Sandercock,
Chief Financial Officer -
Peter Farrell,
Non-Executive Chairman of the Board -
Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD,
Founder & Non-Exec. Chairman -
Dr. Peter C. Farrell A.M., B.E., Ph.D., BE (Hons), ScD, AM,
Founder & Non-Exec. Chairman -
Ronald Taylor,
Lead Independent Director -
Carol Burt,
Independent Director -
Richard Sulpizio,
Independent Director -
Harjit Gill,
Independent Director -
Jan De Witte,
Independent Director -
Karen Drexler,
Independent Director -
Justin Leong,
President – Asia and Latin America -
Urvashi Tyagi,
Chief Technology Officer -
Nupur Bhushan,
Chief People Officer -
David B. Pendarvis,
Chief Admin. Officer, Global Gen. Counsel & Corp. Sec. -
Amy Wakeham,
VP of Investor Relations & Corp. Communications -
Constance C. Bienfait,
Director of Investor Relations -
Kaushik Ghoshal,
Pres of SaaS Bus. & CTO -
John P Wareham,
Director -
Christopher G Roberts,
Director -
Donald Darkin,
Sr. Vice President, Pat Inter -
Gary W Pace,
Director -
Anne Reiser,
President - ResMed Europe -
Richard Mc Hale,
President, RC Business -
Inc Resmed,
Director -
James Hollingshead,
President, Sleep Business -
Kieran Gallahue,
President, Global -
Paul Eisen,
Vice President, Europe & Asia -
Donagh Mccarthy,
Director -
Adrian M Smith,
CFO -
Klaus H Shindhelm,
Sr. Vice President, Operations -
Keith Serzen,
Chief Operating Officer -
Louis A Simpson,
Director -
Christopher Bartlett,
Director -
Walter Flicker,
VP and Asst. Corp. Secretary -
Lasse Beijer,
COO-Europe -
Stein Jacobsen,
COO, Europe -
Michael A Quinn,
Director -
Kaushik Ghoshal,
President, SaaS Business -
Lucile Blaise,
President, Sleep & RC Business -
John Hernandez,
Director -
Desney Tan,
Director -
Michael J Rider,
Global General Counsel -
Christopher Del Orefice,
Director